Mobio Interactive offers a remote patient monitoring platform that utilizes facial photoplethysmography and deep neural networks to objectively assess therapy effectiveness in mental health treatment. This technology enables personalized interventions that have been clinically validated to reduce anxiety, depression, and stress across diverse patient populations.
Funding
$4.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OIFounders
Product
Problem
Mental health treatment often lacks objective measures of therapy effectiveness, hindering the ability to personalize interventions and optimize patient outcomes. Traditional methods rely heavily on subjective self-reports, which can be influenced by various biases and may not accurately reflect a patient's true progress. This makes it difficult for clinicians to make informed decisions about treatment adjustments.
Solution
Mobio Interactive offers a remote patient monitoring platform, AmDTx, that uses facial photoplethysmography (PPG) and deep neural networks to provide objective assessments of mental wellbeing and therapy effectiveness. The platform quantifies psychological stress by analyzing biomarker data points captured via facial scanning, correlated with self-reported data. This "measure-treat-measure" system enables personalized treatment plans and has demonstrated reductions in anxiety, depression, and stress across diverse patient populations in clinical trials. The platform is available in multiple languages and integrates into clinical practices, providing clinicians with data-driven insights for treatment decisions.
Target Audience
The primary target audience includes health systems seeking to improve patient outcomes and personalize therapy, payors aiming to provide preventative mental health tools to policyholders, and pharmaceutical companies looking for digitally-enabled pharmacotherapy solutions and objective clinical endpoints.
Features
- AI-powered remote patient monitoring using facial photoplethysmography (PPG)
- Deep neural networks trained on a large dataset of over 3 million biomarker data points and self-reports
- Objective quantification of psychological stress and mental wellbeing
- Personalized treatment recommendations based on real-time data analysis
- Integration with existing clinical workflows and electronic health record (EHR) systems
- Digital biomarker SDK and psychotherapy library API for integration into existing systems
- DCB 0129 and ISO 27001 certified; GDPR-, HIPAA- and PHIPA-compliant